KOKazuyoshi Okada

Kazuyoshi Okada

*This is an algorithmically generated author record based on publicly available information.

Kazuyoshi Okada has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of switching from lanthanum carbonate to tenapanor on CKD‒MBD management

    by Kazuyoshi Okada, Manabu Tashiro, Ikuko Shimizu, Tomoko Inoue, Jun Minakuchi

    腸管でのNa/H交換輸送体3阻害薬(テナパノル)により厳格な血清リン濃度の管理が期待でき,今回,炭酸ランタンをテナパノルに切り替え,除外基準に該当しない維持血液透析患者27名を後ろ向きに検討した.下痢により,12例(44.4%)が脱落し,除外基準に該当した5例を除いた10例で解析した.リン低下薬錠数は,開始時4.6±1.9錠から12週後2.4±0.9錠と有意に(p<0.01)減少した.血清リン濃度は,開始時5.4±0.9 mg/dLから8週後4.2±0.5 mg/dL,10週後3.9±0.9 mg/dLと有意に(p<0.05,p<0.01)低下した.なお,テナパノルの最終投与量は29.0±13.7 mg/日であった.炭酸ランタンからテナパノルへの切り替えにより,血清リン濃度のコントロールが良好になるとともにポリファーマーシーも改善した.しかし,下痢が開始用量でも高率に発生したため,患者指導により忍容性を高めることが重要である.

  • Open Access

    Impact of Albumin Leakage on the Mortality of Patients Receiving Hemodialysis or Online Hemodiafiltration

    by Manabu Tashiro, Kazuyoshi Okada, Yusaku Tanaka, Hiroyuki Michiwaki, Hisato Shima, Tomoko Inoue, Toshio Doi, Jun Minakuchi

    Background: Online hemodiafiltration (OHDF) has a lower mortality rate than hemodialysis (HD). We aimed to investigate the impact of the albumin leakage on the mortality of patients receiving HD or OHDF. Methods: In this single-center study, consecutive patients receiving renal replacement therapy between January and April 2018 were retrospectively registered. Using (1:1) propensity score matching, 3-year all-cause mortality was compared between patients receiving HD and OHDF, and the impact of albumin leakage on the mortality rate in both groups was investigated. Results: Of the 460 patients, 137 patients receiving HD were matched with an equal number of patients receiving OHDF. OHDF was associated with higher albumin leakage (p < 0.001) and a lower mortality than HD (log-rank test, p < 0.001). Albumin leakage was associated with mortality in patients receiving HD (per 1 g increase, hazard ratio (HR): 0.495, 95% confidence interval (CI): 0.275–0.888) and patients receiving OHDF (per 1 g increase, HR: 0.734, 95% CI: 0.588–0.915). Patients receiving HD, with the highest albumin leakage tertile (>3 g), had a similar mortality rate to patients receiving OHDF, with similar albumin leakage. Conclusions: The negative relationship between albumin leakage and mortality suggests the benefit of removing middle- to -large-molecular-weight substances to improve survival.